Tesla Stock Leads These Founder Run Picks In AI And Automation

Founder led companies can offer something many investors look for, especially when growth signals, inflation trends and interest rate decisions are all pulling attention in different directions. When the person who set the vision is still in charge, incentives can be closely aligned with long term shareholders, whether the focus is on services, manufacturing, energy or consumer facing businesses. In a world of shifting PMIs, changing tariff policies and persistent energy price questions, this Founder Led Companies screener is designed to highlight leaders with skin in the game. Below are three stocks from the screener that stand out for closer research.

UiPath (PATH)

Overview: UiPath is an automation software company that helps businesses use AI agents and software robots to handle repetitive processes, from back office workflows to testing and quality assurance, across sectors such as financial services, healthcare, manufacturing, retail and government.

Operations: UiPath generates about US$1.7b in revenue from Software & Programming, with around US$738.8m from the United States and further revenue across Europe, the Middle East and Africa and the rest of the Americas.

Market Cap: US$5.54b

UiPath gives investors exposure to automation and agentic AI at a time when many companies are trying to cut costs and speed up workflows. Its recent move into profitability with US$418.38m in quarterly revenue and US$22.53m in net income shows the business model can support earnings. The stock currently trades on a P/E below many software peers, and the company still has to manage headwinds from foreign exchange, deal timing and the shift toward SaaS that is weighing on near term growth. That mix of profitability, AI exposure and real transition risk is what makes UiPath worth a closer look for founder led opportunities.

UiPath’s shift to earnings and AI focus could be masking what really matters for long term holders. See how the DCF valuation analysis for UiPath frames that trade off and what the cash flows might be missing.

Tesla (TSLA)

Overview: Tesla is a US based company that designs, builds, sells and leases electric vehicles and also develops energy storage and solar products, supported by its own charging network, financing, insurance and software offerings such as self driving and vehicle infotainment. Beyond cars, Tesla provides home and grid scale batteries, solar panels and solar roofs, backed by installation, servicing and various financing options for residential, commercial and utility customers.

Market Cap: US$1.40t

Tesla attracts attention because it sits at the crossroads of electric vehicles, AI driven self driving software, humanoid robotics and large scale energy storage. However, today most of its cash flow is still tied to relatively low margin car sales. Earnings fell 35.3% last year and profit margins are a modest 3.7%. Analysts expect earnings growth above 20% a year and revenue growth ahead of the wider US market, which helps explain why the stock trades on a rich P/S multiple. At the same time, investors are weighing heavy AI and robotics capex, regulatory scrutiny around Autopilot and FSD, and ongoing litigation against the potential upside from robotaxis, Optimus and a growing Megapack backlog that could all materially reshape Tesla’s earnings mix over time.

Tesla’s earnings may look stalled, but the real story is how expectations for self driving, robotics and energy could reshape the whole equation. See how the analyst forecasts for Tesla reframes what the market might be missing

Hinge Health (HNGE)

Overview: Hinge Health is a digital health company that uses software, AI powered motion tracking and connected wearables to deliver musculoskeletal care for issues like chronic back pain, joint problems and post surgery rehab, mainly to large self insured employers and health plans.

Operations: Hinge Health generates about US$646.3m in revenue from Healthcare Software.

Market Cap: US$6.12b

Hinge Health is drawing attention because it combines fast growing healthcare software revenue with a large installed base of about 24.6 million contracted lives across more than 2,800 clients, including many Fortune 500 employers. Its AI tools and the Robin assistant are already supporting higher member volumes without rising care team costs. This ties directly to the margin story that bullish analysts and recent guidance upgrades are focused on. At the same time, the company is still unprofitable, carries high funding risk and pays rich executive compensation, so expectations are high. The key question for investors is whether its data advantage, new programs like HingeSelect and fresh federal and Medicare channels can outweigh those pressures and justify current pricing over time.

Hinge Health’s rapid member growth and AI tools are impressive, but the real story may be how margins and funding risk interact. See how the analyst forecasts for Hinge Health reframes what could be quietly building in the background.

The three founder led companies here are only a small sample, with the full Founder-Led Companies screener surfacing more than 350 other businesses where the person who set the vision is still driving the outcome. Use Simply Wall St to identify and analyze the specific catalysts and narratives that matter to you so you can focus on the founder led stories that best fit your highest conviction ideas.

Take Control of Your Investment Journey

If Hinge Health or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Alternatives Before Everyone Else?

Fresh stock ideas can move from quiet to flying once momentum builds, so do not get caught reacting after prices move. Scan these curated picks while it matters and consider them before many other investors do.

• Target steady cash flows and balance sheet strength by reviewing a curated list of solid balance sheet and fundamentals (48 results) that helps you focus on durability before the crowd chases safety.
• Explore potential AI-related opportunities by checking a hand picked group of 64 profitable AI stocks that aren't just burning cash that already pair real earnings with sector buzz, rather than just burning cash.
• Review long term electrification themes by scanning curated 35 power grid technology and infrastructure stocks that could be relevant as infrastructure spending focuses on keeping grids resilient and reliable.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.